课题基金 / 基金详情

ALTERED EXPRESSION OF TRANSCRIPTION FACTOR FOR CD19 GENE IN HUMAN MYELOMA CELLS

ALTERED EXPRESSION OF TRANSCRIPTION FACTOR FOR CD19 GENE IN HUMAN MYELOMA CELLS
人骨髓瘤细胞中 CD19 基因转录因子表达的改变
批准号:
07671209
负责人:
TANAKA Hideo
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

TANAKA Hideo的其他基金

相似基金

相关文献

中文摘要
翻译
骨髓瘤细胞表面不表达CD19,而正常浆细胞表达CD19。我们认为CD19的这种表达缺失与人骨髓瘤的发生有关,并进行了这项研究。我们的研究表明,骨髓瘤细胞CD19表达的缺失是由于CD19基因表达缺失所致。此外,还发现CD19基因表达的缺失是由于Pax-5基因表达改变所致。凝胶漂移实验也证实Pax-5基因编码的BSAP在骨髓瘤细胞中没有检测到功能活性。由于Pax-5基因在人骨髓瘤细胞中的表达发生改变,我们试图克隆和分析人Pax-5基因的调控区,以阐明Pax-5基因表达的调控机制。我们用基因步行法克隆了人Pax-5基因5‘上游1050bpDNA片段,并对该片段中预测的结合基序进行了分析。该片段含有Ikaros-2(Ik-2)、Lyf-1(Ik-1)、bHLH、E-47、SOX-5等结合基序。在该DNA片段的缺失突变实验中,其基本启动子活性位于Pax-5基因上游-70~-820碱基之间。因此,我们的研究表明,在不表达CD19的人骨髓瘤细胞中,Pax-5基因的表达发生了变化,我们克隆了人Pax-5基因5‘端1050bp5’上游区域,并对其进行了功能分析。对克隆的人Pax-5基因启动子区域的进一步分析将有助于了解人骨髓瘤的致癌机制。
英文摘要
Myeloma cells do not express CD19 on their surface, while normal plasma cells do. We considered that this loss of CD19 expression is involved in oncogenesis of human myeloma, and performed this project. Our study clarified that loss of CD19 expression on myeloma cells is derived from loss of expression of CD19 gene. Furthermore, it was revealed that loss of CD19 gene expression result from altered expression of Pax-5 gene. It was also confirmed that the functional activity of BSAP encoded by Pax-5 gene was not detected from myeloma cells by gel shift assay. Since expression of Pax-5 gene is altered in human myeloma cells, we tried to clone and analyze regulatory region of human Pax-5 gene in order to clarify the regulatory mechanism of Pax-5 gene expression. We cloned 1,050 bp 5' upstream region of human Pax-5 gene by PCR-mediated gene walking method, and analyzed predicted binding motifs in this DNA fragment. This fragment contained binding motifs of Ikaros-2 (Ik-2), Lyf-1 (Ik-1), bHLH,E-47, Sox-5 et al. In the experiment of deletion mutants of this DNA fragment, the basal promoter activity was located in the region from-70 bp to -820 bp upstream of Pax-5 gene. Therefore, our study showed that the expression of Pax-5 gene is altered in human myeloma cells that do not express CD19, and we cloned and functionally analyzed 1,050 bp 5' upstream region of human Pax-5 gene. The further analysis of this cloned promoter region of human Pax-5 gene will contribute to the understanding of oncogenic mechanism of human myeloma.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Tsujimoto T et al.: "Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells." Blood. 87. 3375-3383 (1996)
Tsujimoto T 等人:“浆细胞通过与骨髓基质细胞相互作用诱导前 B 细胞凋亡。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Huang, N. et al.: "Expression of CD21 antigen on myeloma cells and its involvement in their adhesion to bone marrow stromal cells." Blood. 85. 3704-3712 (1995)
Huang, N. 等人:“骨髓瘤细胞上 CD21 抗原的表达及其与骨髓基质细胞粘附的关系。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Roles of T tubular distribution in genesis of atrial fibrillation
    • 批准号:
      15K08407
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2015
    • 负责人:
      TANAKA Hideo
    • 依托单位:
    Role of fibrosis and mechanical stretch in the genesis of atrial fibrillation
    • 批准号:
      24590487
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Hideo
    • 依托单位:
    Barbarism and Enlightenment-elusidation from the history of economic thought
    Role of gap-junctional coupling between cardiomyocytes and stromal cells in genesis of cardiac arrhythmias
    • 批准号:
      21590420
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      TANAKA Hideo
    • 依托单位:
    国内基金
    海外基金
    POLD1启动子区甲基化岛、转录因子PAX-5/E2F-1的发现与验证及复制性衰老过程中POLD1转录调控机制的研究
    • 批准号:
      81871714
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      王培昌
    • 依托单位: